Emcure Pharmaceuticals IPO aimed to raise ₹1,952.03 crore. The IPO, which opened for subscription on July 3, 2024, and closed on July 5, 2024, consisted of a fresh issue of 0.79 crore shares aggregating to ₹800 crore and an offer for sale of 1.14 crore shares aggregating to ₹1,152.03 crore. The Emcure IPO allotment status is set to be finalised today.

If you applied for the IPO, here is how you can check the Emcure IPO allotment status.

Checking Allotment Status on Registrar's Website:

Follow these steps to check the Emcure IPO allotment status

1. Visit the registrar's website.
2. Click on "Company Selection" and choose "Emcure Pharmaceuticals” from the dropdown menu.
3. Then you can enter your PAN, application number, or Demat.
4. Click Submit to retrieve the Emcure IPO allotment status

Checking IPO Allotment Status on BSE:

1. Go to the BSE website.
2. Click on the ‘Equity' section and select "Emcure Pharmaceuticals" from the dropdown menu.
3. Enter your application number or PAN.
4. Click on the ‘Search' button.
5. The result will show the number of shares allotted to you.

If all the details are entered correctly and the allotment has been finalised, the Emcure PO allotment status will be visible.

See Also: IREDA, HCLTech And 3 Tata Stocks Are Set To Report Q1 Earnings This Week

Emcure IPO Subscription Status

On the final day of bidding, the Emcure Pharma IPO has seen a subscription status of 67.87 times. The retail investor portion was subscribed 7 times, and non-institutional investors (NII) saw a subscription of 48 times. The Qualified Institutional Buyers (QIBs) portion was subscribed 195 times.

Emcure IPO GMP

The Emcure IPO GMP is currently reported at ₹390. With the upper price band of the IPO at ₹1,008, the stock is expected to list at ₹1,398, indicating a premium of around 38% on listing. However, it’s crucial to remember that while GMPs can provide some insight into market sentiment towards an IPO, they are not always a reliable predictor of the stock’s performance upon listing.

Emcure IPO Details

The Emcure IPO is set with a price band of ₹960 to ₹1,008 per share, requiring a minimum lot size of 14 shares per application. The company plans to utilize the net proceeds from the IPO for various purposes including prepayment or scheduled repayment of existing borrowings, financing working capital needs, and general corporate purposes. The shares are expected to be listed on both the BSE and NSE on Wednesday, July 10, 2024.

Ahead of its IPO, Emcure successfully raised ₹582.6 crores from anchor investors on July 2, 2024. This involved allocating 57.79 lakh equity shares at ₹1,008 per share to anchor investors, with notable participants including the Abu Dhabi Investment Authority, Goldman Sachs, and Morgan Stanley.

Emcure Pharma Details

Established in 1981, Emcure Pharmaceuticals develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas. Backed by Namita Thapar, the company is ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and holds the 4th position in market share within its covered markets for the same period.

Read Next: Tata's N Chandrasekaran's Salary Was ₹37.63 Lakh When TCS Went Public In 2004, Here's How Much Ratan Tata Was Paid